Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Conestoga Micro Cap Composite 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Conestoga Micro Cap Composite)

Primary Source Intelligence • Q1 2024 Letter Analysis

Conestoga Micro Cap Composite Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Conestoga Micro Cap Composite. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+10.58%

Digest Analysis

Quick Take

"Palomar Holdings and Digi International drove outperformance while regulatory headwinds hit healthcare names. The manager actively repositioned the portfolio, selling challenged positions and adding Bowman Consulting to capitalize on infrastructure spending trends."

Executive Summary

The Conestoga Micro Cap Growth Composite advanced 4.93% net-of-fees in Q1 2024 but trailed the Russell Micro Cap Growth Index's 6.60% return. Stock selection was negative but partially offset by positive sector allocation effects. The portfolio benefited from strong performance in Financials and Telecommunications sectors, led by Palomar Holdings which rose over 50% after pivoting to better underwriting markets, and Digi International which reported above-expectations results. However, Industrials and Health Care sectors detracted from performance. SoundThinking faced concerns about a potential Chicago contract loss, while health care companies like Semler Scientific and Alpha Teknova struggled with regulatory challenges and capital preservation in early-stage biopharma. The manager sold positions in Semler Scientific and Douglas Dynamics due to reduced visibility and factors outside management control, while adding Bowman Consulting Group to benefit from infrastructure spending tailwinds. The portfolio continues to focus on companies with strong secular growth drivers despite near-term sector headwinds.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The manager demonstrates moderate-high conviction through active portfolio management, selling positions to zero when thesis breaks down and adding new names with clear secular tailwinds. The portfolio is concentrated with top 10 holdings representing 43.53% of assets, and the manager provides detailed thesis explanations for individual positions.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager expresses cautious optimism about the underlying economy headed for a softer landing and moderating inflation, but acknowledges that small caps have underperformed large caps for 14 years and their call for a new small cap cycle is running behind schedule.

Risk Appetite

15%

DefensiveAggressive

Defensive (15%)

The manager is selectively positioned, actively selling positions with reduced visibility (SMLR, PLOW) and adding new names (BWMN), indicating a measured approach to risk rather than aggressive deployment.

Capital Deployment

5%

De-riskingDeploying

De-risking (5%)

The manager engaged in capital rotation, selling two positions (SMLR, PLOW) and adding one new position (BWMN), with additional trimming and adding across eight and two occasions respectively. This represents reallocation rather than net deployment or de-risking.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

The manager expects a more positive second half of 2024 for biotechnology and is actively repositioning capital toward better opportunities, showing a constructive but selective deployment bias.

Language Signal

20%

BearishBullish

Bearish (20%)

Language is balanced with mentions of both opportunities (infrastructure spending, secular tailwinds) and challenges (regulatory headwinds, capital preservation), with slightly more cautious than bullish directional language.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

The manager acknowledges moderate risks including small cap underperformance, stylistic headwinds, and sector-specific challenges in biotechnology, but these are presented as manageable headwinds rather than systemic threats.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

The manager sees selective opportunities, evidenced by adding a new position in Bowman Consulting and maintaining optimism about long-term potential for companies like SoundThinking despite near-term challenges. The focus on secular tailwinds suggests a moderately rich opportunity set in specific areas.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The manager demonstrates a multi-year investment horizon, maintaining positions through volatility while acknowledging that some recoveries may take longer than originally anticipated. The focus on secular tailwinds and long-term potential suggests a patient capital approach typical of growth investing.